Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

Cited In for PubMed (Select 10559355)

1.

Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.

Nonnenmacher ME, Cintrat JC, Gillet D, Weber T.

J Virol. 2015 Feb;89(3):1673-87. doi: 10.1128/JVI.02520-14. Epub 2014 Nov 19.

PMID:
25410859
2.

Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.

Weinberg MS, Nicolson S, Bhatt AP, McLendon M, Li C, Samulski RJ.

J Virol. 2014 Nov;88(21):12472-84. doi: 10.1128/JVI.01971-14. Epub 2014 Aug 20.

3.

Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.

Bilkova E, Forstova J, Abrahamyan L.

Viruses. 2014 Jul 23;6(7):2899-937. doi: 10.3390/v6072899. Review.

4.

Cellular unfolded protein response against viruses used in gene therapy.

Sen D, Balakrishnan B, Jayandharan GR.

Front Microbiol. 2014 May 26;5:250. doi: 10.3389/fmicb.2014.00250. eCollection 2014. Review.

5.

Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Nicolson SC, Samulski RJ.

J Virol. 2014 Apr;88(8):4132-44. doi: 10.1128/JVI.02660-13. Epub 2014 Jan 29.

6.

Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway.

Hirsch ML, Li C, Bellon I, Yin C, Chavala S, Pryadkina M, Richard I, Samulski RJ.

Mol Ther. 2013 Dec;21(12):2205-16. doi: 10.1038/mt.2013.184. Epub 2013 Aug 13.

7.

A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Koirala A, Conley SM, Naash MI.

Biomaterials. 2013 Sep;34(29):7158-67. doi: 10.1016/j.biomaterials.2013.06.002. Epub 2013 Jun 22. Review.

8.

Adeno-associated virus capsid antigen presentation is dependent on endosomal escape.

Li C, He Y, Nicolson S, Hirsch M, Weinberg MS, Zhang P, Kafri T, Samulski RJ.

J Clin Invest. 2013 Mar;123(3):1390-401. doi: 10.1172/JCI66611. Epub 2013 Feb 1.

9.

Activation of the cellular unfolded protein response by recombinant adeno-associated virus vectors.

Balakrishnan B, Sen D, Hareendran S, Roshini V, David S, Srivastava A, Jayandharan GR.

PLoS One. 2013;8(1):e53845. doi: 10.1371/journal.pone.0053845. Epub 2013 Jan 8.

10.
11.

Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Popa-Wagner R, Porwal M, Kann M, Reuss M, Weimer M, Florin L, Kleinschmidt JA.

J Virol. 2012 Sep;86(17):9163-74. doi: 10.1128/JVI.00282-12. Epub 2012 Jun 13.

12.

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL.

Curr Gene Ther. 2012 Jun;12(3):139-51. Review.

13.

Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway.

Nonnenmacher M, Weber T.

Cell Host Microbe. 2011 Dec 15;10(6):563-76. doi: 10.1016/j.chom.2011.10.014.

14.

AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.

Johnson JS, Gentzsch M, Zhang L, Ribeiro CM, Kantor B, Kafri T, Pickles RJ, Samulski RJ.

PLoS Pathog. 2011 May;7(5):e1002053. doi: 10.1371/journal.ppat.1002053. Epub 2011 May 19.

15.

Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells.

Keiser NW, Yan Z, Zhang Y, Lei-Butters DC, Engelhardt JF.

Hum Gene Ther. 2011 Nov;22(11):1433-44. doi: 10.1089/hum.2011.044. Epub 2011 Jun 28.

16.

Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates.

Joo KI, Fang Y, Liu Y, Xiao L, Gu Z, Tai A, Lee CL, Tang Y, Wang P.

ACS Nano. 2011 May 24;5(5):3523-35. doi: 10.1021/nn102651p. Epub 2011 Apr 13.

17.

Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.

Johnson JS, Li C, DiPrimio N, Weinberg MS, McCown TJ, Samulski RJ.

J Virol. 2010 Sep;84(17):8888-902. doi: 10.1128/JVI.00687-10. Epub 2010 Jun 23.

18.

Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A.

Hum Gene Ther. 2010 Mar;21(3):271-83. doi: 10.1089/hum.2009.100.

19.

A differential role for endocytosis in receptor-mediated activation of Nox1.

Miller FJ Jr, Chu X, Stanic B, Tian X, Sharma RV, Davisson RL, Lamb FS.

Antioxid Redox Signal. 2010 Mar 1;12(5):583-93. doi: 10.1089/ars.2009.2857.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk